SCHEMBL6180762

SCHEMBL6180762

CCCCCS(=O)(=O)NC(=O)c1ccc(NC(C)=O)c(N(C)Cc2ccc(Cl)cc2Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.52
SCN9A Q15858 1/20 0.39
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KMT2A Q03164 1/20 0.37
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6181099 0.86 PPARG (0.54) PPARGSCN9AALDH1A1GAAHTT
SCHEMBL6180764 0.74 THRB (0.37) PPARGALDH1A1GAAHTT
SCHEMBL6134825 0.73 PPARG (0.58) PPARGHDAC1HDAC8HDAC6PTPN1
SCHEMBL6181163 0.71 PPARG (0.55) PPARGALDH1A1GAAHDAC1HDAC8
SCHEMBL6172090 0.70 PPARG (0.54) PPARGHDAC1HDAC8HDAC6
SCHEMBL6168579 0.70 ERAP2 (0.47) PPARGALDH1A1GAAHTTHDAC1
SCHEMBL6305809 0.70 PPARG (0.54) PPARGPTPN1
SCHEMBL5881961 0.70 PPARG (0.54) PPARG
SCHEMBL6306158 0.70 PPARG (0.68) PPARG
SCHEMBL5882208 0.70 PPARG (0.75) PPARGHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000932-B9 AROMATIC RING DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-12-28 EP disclosed
EP-1000932-B1 AROMATIC RING DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2004-09-15 EP disclosed
US-6242474-B1 SULFONYLCARBAMOYLALKYLIMIDAZOLE DERIVATIVES; ANTIDIABETIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-05 US disclosed
EP-1000932-A1 AROMATIC RING DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-17 EP disclosed